Hematologic Oncology Update cover image

Oncology Today with Dr Neil Love — Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition

Hematologic Oncology Update

00:00

Benetuzumab and Benetoclax: A Comparison

You would expect that quality of life would be better than continuous BTK. But what about comparing it to just a Benetuzumab, Benetoclax in terms of the patient experience? How would you compare it? And again, I don't know to what extent patient reported outcomes have been done for all these studies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app